Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV - Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

NCT01063218 is registered in ClinicalTrials.gov with Galderma Brasil Ltda. as lead sponsor.

NCT NCT01063218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01063218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV - Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application
Lead sponsor
Galderma Brasil Ltda.
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
October 31, 2010
Enrollment
74 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic